艾美疫苗（股票代码：06660）于2026年7月2日发布截至2026年6月30日的股份变动月报。报告显示，公司注册股本合计1,226,562,599元人民币，包括H股507,673,711股、内资股718,888,888股，面值均为每股人民币1元。上述注册股本数量与上月底保持一致。
根据月报，H股发行总数从上月底的507,673,711股维持不变，内资股则保持在718,888,888股，未出现新增发行、购回或注销情况。期权及股权激励计划也无相关增减记录。
截至本月末，公司股本总额未发生变动，维持稳定。公司在公告中确认，已严格遵守香港联交所《上市规则》及其他适用法律法规。
本次公告由公司秘书刘灵签署。公司表示将持续披露后续股本变动信息。期待进一步加强与投资者的沟通与信息交流。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.